Company PAVmed Inc.

Equities

PAVM

US70387R4039

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Ratings for PAVmed Inc.

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 10:00:22 2024-04-18 am EDT			5-day change	1st Jan Change
1.925 ^USD	-2.28%		-2.50%	-52.67%

Mar. 27	Transcript : PAVmed Inc., Q4 2023 Earnings Call, Mar 27, 2024
Mar. 25	PAVmed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is focused on enhanced personalized cancer care through remote patient monitoring using implantable vascular access port with wireless communication combined with an oncologist-designed remote digital healthcare platform.

Number of employees: 107

USD in Million	2022	Weight	2023	Weight	Delta
Diagnostics, Medical Devices and Digital Health 100.0 %	0	100.0 %	2	100.0 %	+550.40%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	2	100.0 %	+550.40%

Managers	Title	Age	Since
Lishan Aklog CEO	Chief Executive Officer	58	14-06-25
Dennis McGrath DFI	Director of Finance/CFO	67	17-03-20
Suman M. Verma CTO	Chief Tech/Sci/R&D Officer	-	21-10-20
Shaun O’Neil COO	Chief Operating Officer	42	18-07-22
Brian deGuzman CMP	Compliance Officer	60	14-09-30
Michael Parks IRC	Investor Relations Contact	-	-
Michael Gordon LAW	General Counsel	50	22-04-30
James Mitchell PRN	Corporate Officer/Principal	-	21-05-31

Members of the board	Title	Age	Since
James Cox BRD	Director/Board Member	81	14-12-31
Ronald Sparks BRD	Director/Board Member	69	14-12-31
Debra White BRD	Director/Board Member	62	21-04-21
Timothy Baxter BRD	Director/Board Member	63	21-06-09
Michael Glennon BRD	Director/Board Member	58	14-09-30
Lishan Aklog CEO	Chief Executive Officer	58	14-06-25
Joan Harvey BRD	Director/Board Member	57	22-02-10

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	1,305,213	0	0	92.77 %
Stock B	1	9,172,331	8,508,873 ( 92.77 %)	0

Name	Equities	%	Valuation
Ayrton Capital LLC 4.175 %	382,976	4.175 %	819 569 $
Lishan Aklog 4.112 %	377,164	4.112 %	807 131 $
Michael Glennon 3.434 %	315,000	3.434 %	674 100 $
Vanguard Global Advisers LLC 3.299 %	302,606	3.299 %	647 577 $
Pavilion Venture Partners LLC 3.239 %	297,106	3.239 %	635 807 $
First Manhattan Co LLC 2.180 %	200,000	2.180 %	428 000 $
Ayrton Capital LLC 1.631 %	149,616	1.631 %	320 178 $
BlackRock Institutional Trust Co. NA 0.8168 %	74,922	0.8168 %	160 333 $
Joan Harvey 0.7087 %	65,000	0.7087 %	139 100 $
James Cox 0.7087 %	65,000	0.7087 %	139 100 $

Name	Equities	%	Valuation
UBS Financial Services, Inc. -	600	-	21 $
Bank of America, NA (Charlotte, North Carolina) -	115	-	4 $

Name	Equities	%	Valuation
LUCID DIAGNOSTICS INC. 64.88%	31,302,444	64.88%	25,354,980 $

PAVmed, Inc.

360 Madison Avenue 25th floor

10017, New York

+212 949 4319

http://www.pavmed.com

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.97 USD

Average target price

15.38 USD

Spread / Average Target

+680.46%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
PAVMED INC.	-52.67%	18.07M
THERMO FISHER SCIENTIFIC	+1.62%	209B
DANAHER CORPORATION	+1.79%	177B
INTUITIVE SURGICAL, INC.	+9.89%	133B
BOSTON SCIENTIFIC CORPORATION	+16.86%	99.89B
SIEMENS HEALTHINEERS AG	-2.51%	61.83B
EDWARDS LIFESCIENCES CORPORATION	+13.25%	52.51B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.21%	45.54B
AGILENT TECHNOLOGIES, INC.	-4.27%	39.43B
GE HEALTHCARE TECHNOLOGIES INC.	+10.55%	38.87B

Other Advanced Medical Equipment & Technology